Phillygenin, a MELK Inhibitor, Inhibits Cell Survival and Epithelial–Mesenchymal Transition in Pancreatic Cancer Cells

Phillygenin, a MELK Inhibitor, Inhibits Cell Survival and Epithelial–Mesenchymal Transition in Pancreatic Cancer Cells

Hongchun Li,1 Miao Chen,2 Zhuying Yang,3 Qinxian Wang,1 Jiesheng Wang,1 Dong Jin,1 Xiuyun Yang,1 Fuxing Chen,1 Xiumin Zhou,4 Kexue Luo1 1Department of Cadre Health, Tongde Hospital of Zhejiang Province, Hangzhou 310012, Zhejiang, People’s Republic of China; 2Department of Oncology, Tongde...

Full description

Bibliographic Details
Main Authors: Li H, Chen M, Yang Z, Wang Q, Wang J, Jin D, Yang X, Chen F, Zhou X, Luo K
Format: Article
Language:English
Published: Dove Medical Press 2020-04-01
Series:OncoTargets and Therapy
Subjects:
pancreatic cancer
phillygenin
melk
proliferation
emt
apoptosis
Online Access:https://www.dovepress.com/phillygenin-a-melk-inhibitor-inhibits-cell-survival-and-epithelialndas-peer-reviewed-article-OTT

Internet

https://www.dovepress.com/phillygenin-a-melk-inhibitor-inhibits-cell-survival-and-epithelialndas-peer-reviewed-article-OTT

Similar Items